Insider trading

Period: 120 months Stock: ARVN Minimum amount: $100K × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

83 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

83 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

83 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

83 decisions over 120 months Remove this filter
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
83 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
83 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

83 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
11 May 2026
Saik Andrew Chief Financial Officer
Sold at will
$110.69K 11,139 at 9.94
5.5%
Not planned
11 May 2026
Berkowitz Noah Chief Medical Officer
Sold at will
$110.38K 11,108 at 9.94
5.5%
Not planned
6 Mar 2026
Morrison Briggs Director
Bought
$268.07K 20,000 at 13.40
26.3%
Largest buy in 3 yrs
27 Feb 2026
Houston John G Director
Sold at will 3×
$466.15K 35,297 at 13.21
3.0%
Not planned
22 Sep 2025
Morrison Briggs Director
Bought
$227.01K 30,000 at 7.57
65.2%
First buy on file
24 Feb 2025
Houston John G President and CEO
Sold at will 2×
$523.88K 31,338 at 16.72
2.6%
Not planned
24 Feb 2025
Taylor Ian President, R&D
Sold at will 2×
$150.75K 9,020 at 16.71
5.4%
Not planned
23 Feb 2024
Houston John G President and CEO
Sold at will
$244.47K 5,196 at 47.05
0.5%
Not planned
1 Mar 2023
Houston John G President and CEO
Sold, plan not stated
$173.58K 5,878 at 29.53
0.6%
14 Apr 2022
Morrison Briggs Director
Sold, plan not stated 3×
$1.39M 20,960 at 66.44
51.2%
Sold half or more
11 Mar 2022
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$1.05M 15,000 at 70.00
8.5%
4 Mar 2022
Houston John G President and CEO
Sold, plan not stated
$385.17K 6,024 at 63.94
0.7%
4 Mar 2022
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$101.86K 1,593 at 63.94
1.0%
15 Feb 2022
Taylor Ian Chief Scientific Officer
Sold, plan not stated 6×
$1.46M 20,000 at 73.02
20.3%
14 Jan 2022
Morrison Briggs Director
Sold, plan not stated 4×
$1.37M 20,960 at 65.55
45.9%
30 Dec 2021
Peck Ronald Chief Medical Officer
Sold, plan not stated 2×
$1.61M 20,000 at 80.61
78.7%
Sold half or more
17 Dec 2021
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$1.05M 15,000 at 70.00
8.7%
16 Dec 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 2×
$5.94M 85,705 at 69.36
31.6%
15 Dec 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 3×
$7.58M 113,536 at 66.81
29.5%
14 Dec 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 3×
$10.30M 156,464 at 65.86
28.9%
15 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 2×
$1.81M 21,284 at 84.87
3.8%
15 Nov 2021
Taylor Ian Chief Scientific Officer
Sold, plan not stated 3×
$1.68M 20,000 at 84.04
20.3%
12 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 3×
$3.39M 39,869 at 84.94
6.6%
11 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 3×
$5.16M 59,799 at 86.23
9.0%
10 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 5×
$1.18M 13,358 at 88.20
2.0%
9 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 3×
$3.04M 33,008 at 91.97
4.7%
8 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 4×
$7.66M 81,054 at 94.45
10.3%
5 Nov 2021
Ratcliffe Liam Director · indirect
Sold, plan not stated 5×
$3.04M 33,094 at 91.84
4.0%
5 Nov 2021
Ratcliffe Liam Director
Sold, plan not stated 6×
$2.28M 24,923 at 91.30
100%
Sold half or more
1 Nov 2021
Houston John G President and CEO
Sold, plan not stated 3×
$3.53M 40,000 at 88.14
4.6%
7 Sep 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 4×
$3.24M 36,411 at 89.09
2.2%
3 Sep 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 2×
$2.77M 32,387 at 85.53
1.9%
2 Sep 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 2×
$4.44M 51,765 at 85.83
2.9%
1 Sep 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 4×
$6.92M 79,437 at 87.05
4.3%
31 Aug 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 2×
$5.08M 59,355 at 85.56
3.1%
30 Aug 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 4×
$5.06M 58,838 at 86.07
3.0%
27 Aug 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 2×
$3.85M 45,026 at 85.42
2.2%
26 Aug 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated
$996.97K 11,712 at 85.12
0.6%
26 Aug 2021
Margus Bradley Albert Director · indirect
Sold, plan not stated
$845.17K 9,940 at 85.03
83.2%
Sold half or more
25 Aug 2021
Margus Bradley Albert Director · indirect
Sold, plan not stated
$1.70M 20,000 at 85.00
62.6%
Sold half or more
25 Aug 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated
$1.21M 14,267 at 85.03
0.7%
24 Aug 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated 2×
$800.82K 9,203 at 87.02
0.4%
23 Aug 2021
SHANNON TIMOTHY M Director · indirect
Sold, plan not stated
$140.73K 1,599 at 88.01
0.1%
16 Aug 2021
Taylor Ian Chief Scientific Officer
Sold, plan not stated 3×
$1.75M 20,000 at 87.30
20.3%
13 Aug 2021
Margus Bradley Albert Director · indirect
Sold, plan not stated
$524.69K 5,828 at 90.03
15.4%
12 Aug 2021
Peck Ronald Chief Medical Officer
Sold, plan not stated
$123.40K 1,363 at 90.54
20.1%
11 Aug 2021
Margus Bradley Albert Director · indirect
Sold, plan not stated
$450.15K 5,000 at 90.03
11.7%
2 Aug 2021
Houston John G President and CEO
Sold, plan not stated 5×
$4.49M 45,922 at 97.83
5.3%
28 Jul 2021
Cassidy Sean A Chief Financial Officer
Sold, plan not stated
$1.72M 17,242 at 100.00
9.8%
30 Jun 2021
Peck Ronald Chief Medical Officer
Sold, plan not stated
$1.53M 20,000 at 76.69
87.9%
Sold half or more
Showing 1–50 of 83. Page 1 of 2 Older →